0102030405
Alogliptin CAS No 850649-61-5 Pharmaceutical Intermediates
02
introduce
7 Jan 2019
Alogliptin, also known as SYR-322, is a key pharmaceutical compound used to treat diabetes. As an integrated production and trading factory, we are committed to providing high-quality Alogliptin (SYR-322) that meets the stringent requirements of the pharmaceutical industry.
02
Physical and chemical properties
7 Jan 2019
-Alogliptin (SYR-322) has good solubility, with a solubility of 67 mg/mL (197.41 mM) in DMSO and 18 mg/mL (53.04 mM) in water. Its exceptional properties make it a valuable asset in the development of diabetes management drugs, helping to improve healthcare and treatment options for people with diabetes.
- Diabetes Management: Alogliptin (SYR-322) is a potent pharmaceutical compound used in the treatment of diabetes, providing an effective treatment option for diabetic patients.
- Integrated production and trading: As an integrated production and trading factory, we ensure that the production and distribution of Alogliptin (SYR-322) meet the highest quality and efficacy standards to meet the diverse needs of the pharmaceutical industry.
- Proven Efficacy: Alogliptin (SYR-322) has proven effective in treating diabetes, making it a valuable asset to the pharmaceutical industry.
Alogliptin (SYR-322) plays a vital role in the pharmaceutical industry and is used in the production of drugs to treat diabetes. Its remarkable physical and chemical properties make it an important component in drug synthesis, helping to improve healthcare and treatment options for patients with diabetes.
Alogliptin (SYR-322) is a high-quality pharmaceutical compound with excellent properties, making it an indispensable ingredient in diabetes management in the pharmaceutical industry. As a reputable integrated manufacturing and trading facility, we are committed to offering top-notch Alogliptin (SYR-322) of the highest quality and efficacy standards to meet the diverse needs of the pharmaceutical industry.